These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 10711927)

  • 1. Effect of decreasing afferent vagal activity with ondansetron on symptoms of bulimia nervosa: a randomised, double-blind trial.
    Faris PL; Kim SW; Meller WH; Goodale RL; Oakman SA; Hofbauer RD; Marshall AM; Daughters RS; Banerjee-Stevens D; Eckert ED; Hartman BK
    Lancet; 2000 Mar; 355(9206):792-7. PubMed ID: 10711927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for a vagal pathophysiology for bulimia nervosa and the accompanying depressive symptoms.
    Faris PL; Eckert ED; Kim SW; Meller WH; Pardo JV; Goodale RL; Hartman BK
    J Affect Disord; 2006 May; 92(1):79-90. PubMed ID: 16516303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ondansetron, a 5-HT3 receptor antagonist, on the dynamic association between bulimic behaviors and pain thresholds.
    Faris PL; Won Kim S; Meller WH; Goodale RL; Hofbauer RD; Oakman SA; Howard LA; Stevens ER; Eckert ED; Hartman BK
    Pain; 1998 Sep; 77(3):297-303. PubMed ID: 9808355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of bulimia nervosa with ondansetron.
    Fung SM; Ferrill MJ
    Ann Pharmacother; 2001 Oct; 35(10):1270-3. PubMed ID: 11675858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluvoxamine in the treatment of binge-eating disorder: a multicenter placebo-controlled, double-blind trial.
    Hudson JI; McElroy SL; Raymond NC; Crow S; Keck PE; Carter WP; Mitchell JE; Strakowski SM; Pope HG; Coleman BS; Jonas JM
    Am J Psychiatry; 1998 Dec; 155(12):1756-62. PubMed ID: 9842788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A placebo-controlled study of fluoxetine in continued treatment of bulimia nervosa after successful acute fluoxetine treatment.
    Romano SJ; Halmi KA; Sarkar NP; Koke SC; Lee JS
    Am J Psychiatry; 2002 Jan; 159(1):96-102. PubMed ID: 11772696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 2: improvement in psychiatric measures.
    Hedges DW; Reimherr FW; Hoopes SP; Rosenthal NR; Kamin M; Karim R; Capece JA
    J Clin Psychiatry; 2003 Dec; 64(12):1449-54. PubMed ID: 14728106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-HT(3) antagonist therapy of bulimia nervosa: a peripherally active agent for a central nervous system eating disorder?
    Hasler WL
    Gastroenterology; 2000 Jul; 119(1):271-2. PubMed ID: 10889184
    [No Abstract]   [Full Text] [Related]  

  • 9. 5-hydroxytryptamine-3 receptor antagonist with or without short-course dexamethasone in the prophylaxis of radiation induced emesis: a placebo-controlled randomized trial of the National Cancer Institute of Canada Clinical Trials Group (SC19).
    ; Wong RK; Paul N; Ding K; Whitehead M; Brundage M; Fyles A; Wilke D; Nabid A; Fortin A; Wilson D; McKenzie M; Ackerman I; Souhami L; Chabot P; Pater J
    J Clin Oncol; 2006 Jul; 24(21):3458-64. PubMed ID: 16849762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alizapride and ondansetron for the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic gynaecological surgery: A double-blind, randomised, placebo-controlled noninferiority study.
    Dewinter G; Teunkens A; Vermeulen K; Devroe S; Van Hemelrijck J; Meuleman C; Vergote I; Fieuws S; Van de Velde M; Rex S
    Eur J Anaesthesiol; 2016 Feb; 33(2):96-103. PubMed ID: 26086285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 1: improvement in binge and purge measures.
    Hoopes SP; Reimherr FW; Hedges DW; Rosenthal NR; Kamin M; Karim R; Capece JA; Karvois D
    J Clin Psychiatry; 2003 Nov; 64(11):1335-41. PubMed ID: 14658948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ghrelin concentrations and cardiac vagal tone are decreased after pharmacologic and cognitive-behavioral treatment in patients with bulimia nervosa.
    Tanaka M; Nakahara T; Muranaga T; Kojima S; Yasuhara D; Ueno H; Nakazato M; Inui A
    Horm Behav; 2006 Aug; 50(2):261-5. PubMed ID: 16643914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary experience with use of a selective 5HT3 receptor antagonist (ondansetron) to prevent high dose chemotherapy induced emesis.
    Parikh PM; Shah SR; Shah SC; Sheth V; Patel RA; Shah KC; Jain PK
    Indian J Cancer; 1996 Mar; 33(1):17-20. PubMed ID: 9063013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of casopitant mesylate, a neurokinin 1 (NK1)-receptor antagonist, in prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy: a randomised, double-blind, placebo-controlled trial.
    Grunberg SM; Rolski J; Strausz J; Aziz Z; Lane S; Russo MW; Wissel P; Guckert M; Wright O; Herrstedt J
    Lancet Oncol; 2009 Jun; 10(6):549-58. PubMed ID: 19428297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tropisetron vs ondansetron for prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy: a randomized double-blind, placebo-controlled study.
    Argiriadou H; Papaziogas B; Pavlidis T; Parlapani A; Georgiou M; Papagiannopoulou P; Papaziogas T
    Surg Endosc; 2002 Jul; 16(7):1087-90. PubMed ID: 12165828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder.
    Appolinario JC; Bacaltchuk J; Sichieri R; Claudino AM; Godoy-Matos A; Morgan C; Zanella MT; Coutinho W
    Arch Gen Psychiatry; 2003 Nov; 60(11):1109-16. PubMed ID: 14609886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De-stabilization of the positive vago-vagal reflex in bulimia nervosa.
    Faris PL; Hofbauer RD; Daughters R; Vandenlangenberg E; Iversen L; Goodale RL; Maxwell R; Eckert ED; Hartman BK
    Physiol Behav; 2008 Apr; 94(1):136-53. PubMed ID: 18191425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial.
    Saito M; Aogi K; Sekine I; Yoshizawa H; Yanagita Y; Sakai H; Inoue K; Kitagawa C; Ogura T; Mitsuhashi S
    Lancet Oncol; 2009 Feb; 10(2):115-24. PubMed ID: 19135415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metoclopramide versus ondansetron for the treatment of vomiting in children with acute gastroenteritis.
    Al-Ansari K; Alomary S; Abdulateef H; Alshawagfa M; Kamal K
    J Pediatr Gastroenterol Nutr; 2011 Aug; 53(2):156-60. PubMed ID: 21788756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term fluoxetine treatment of bulimia nervosa. Fluoxetine Bulimia Nervosa Research Group.
    Goldstein DJ; Wilson MG; Thompson VL; Potvin JH; Rampey AH
    Br J Psychiatry; 1995 May; 166(5):660-6. PubMed ID: 7620754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.